The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Will Be The Estimated Market Size Of The Evithrom Market By 2030?

Historical expansion was primarily propelled by the elevated risks of surgical blood loss, the necessity for swift hemostasis, the initial application of thrombin products, the rising number of trauma cases, and their integration into orthopedic procedures.

The anticipated expansion during the projected timeframe is driven by an increase in surgical procedures, escalating rates of accidents and traumas, the development of hospital facilities, advancements in thrombin compositions, and a heightened emphasis on ensuring surgical safety.

Prominent trends anticipated during the forecast period involve the expanding application of topical hemostatic products, a growing need in cardiovascular surgical procedures, the broadening scope of trauma and emergency medical services, a preference for solutions that facilitate quick clot formation, and the greater uptake of human thrombin-based items.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20069&type=smp

Which Drivers Are Advancing The Evithrom Market Growth?

The evithrom market is anticipated to expand due to an increasing volume of surgical procedures in the coming period. These procedures encompass medical operations or interventions involving the physical modification or handling of bodily tissues and organs. The increase in surgical operations is mainly fueled by progress in medical technology, enhancing the safety and efficiency of surgeries, alongside the growing incidence of chronic conditions necessitating more surgical interventions. Evithrom finds application in surgical settings to manage blood loss by encouraging clot development and improving hemostasis, especially during critical operations like cardiovascular or orthopedic surgeries. For example, data from June 2024, released by the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based non-profit organization, indicated that liposuction was the predominant surgical procedure in 2023, with over 2.2 million performed, while face and head procedures experienced substantial growth, climbing by 19.6% to surpass 6.5 million. Consequently, the escalating volume of surgical procedures is boosting the evithrom market’s expansion.

How Are Different Segment Groups Identified Within The Evithrom Market?

The evithrom market covered in this report is segmented –

1) By Indication: Surgical Hemostasis, Trauma Care

2) By Formulation: Bovine Thrombin, Human Thrombin, Recombinant Thrombin

3) By Distribution Channel: Hospitals, Clinics And Diagnostic Centers, Online Pharmacies

Which Key Players Are Active In The Evithrom Market?

Major companies operating in the evithrom market are Johnson & Johnson Inc.

Access The Complete Evithrom Market Report:

https://www.thebusinessresearchcompany.com/report/evithrom-global-market-report

Which Region Contributes The Most To The Evithrom Market?

North America was the largest region in the evithrom market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evithrom market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.